Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is currently seeking high-quality, innovative submissions to be published in future issues.

Areas of focus include, but are not limited to:

• Isolation and production methods
• Characterization, epitope mapping
• Delivery systems for immunotherapeutic and experimental purposes
• Application of mAbs to elucidate signaling pathways
• Development of immunotherapeutics compounds
• Generation of probes for molecular monitoring
• Creation of diagnostic reagents, experimental and clinical
• Analysis of mAb antagonistic/inhibitory effects
• Cellular and molecular responses to mAb immunization
• Immunoscreening for identification of molecular variants and markers
• New sources for availability of fully characterized mAbs

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy provides targeted peer-reviewed research that advances the understanding of immune responses and the use of immunological methods for therapeutic purposes. Fully refereed, peer-reviewed articles and short communications present current findings in the development and characterization of mAbs across all therapeutic areas. Development of mAbs for all research applications, including probes, inhibitors, and diagnostic reagents is also described.

Benefits of publishing in the Journal include:

• Rapid, high-quality peer review
• Fast and user-friendly electronic submission
• Maximum exposure: readership in more than 170 countries
• Diversity of article types
• Open Access options available